Fangyu Li and Shuoqi Chen are co-first authors
Alzheimer’s disease (AD) is the most common type of dementia. International multilateral cost-of-illness (COI) studies have revealed that the cost of treating this disease is huge, which places a significant burden on patients’ families and their healthcare systems. However, no such studies have been conducted in China. This study estimates the monetary costs of patients with AD in mainland China.
This study planned to start in October 2015 and to finish in March 2016. It covered 30 provincial, municipal, and autonomous regions in mainland China. The sites and research centres in each region were selected randomly. The participating sites include Tier 3 hospitals, psychiatric hospitals, geriatric hospitals, nursing homes, and residences. More than 2500 patients with AD and their caregivers from all of the 81 research centres will be enrolled to fulfil the calculated sample size. The monetary costs of AD, which include direct medical costs, direct non-medical costs, and indirect costs, are being collected using the electronic medical record system and residence health system at each site; face-to-face interviews are being performed when necessary. Descriptive statistics will be used to summarise the patient characteristics and generalised linear models will be developed to calculate the costs.
The main findings will include national and per patient annual monetary costs of AD in China.
To the best of our knowledge, this is the first large-scale cluster-randomized observational study to estimate the economic burden of AD in Chinese patients. The methodology used was based on China’s current healthcare system and is suitable for the purpose of the study. Because the burden of AD on patients, families, healthcare providers, and society is substantial and increasing, it is important and necessary to understand the economic burden caused by this disease.
Our trial was retrospectively registered on ClinicalTrials.gov, NCT02694445, registered on 02/26/2016
The main data announcement of Sixth national census. 2011. http://www.stats.gov.cn/ztjc/zdtjgz/zgrkpc/dlcrkpc/dcrkpcyw/201104/t20110428_69407.htm, 2011-04-28. Accessed 7 Aug 2015.
Liu N, Zhang J, Guo L. Alzheimer’s disease epidemiological situation. J Liaoning Univ Tradit Chin Med. 2011;01:35–6.
Lei T, Ma Y, Nie H, et al. China’s current old age dementia prevalence of Meta-analysis. Mod Prev Med. 2012;39(4):809–11. 814.
Guangzhou Biaodian medical information Co., LTD. Anti-dementia drug market research report. Guangzhou: Industry information service of Minei website, 2012.
Leibson CL, Long KH, Ransom JE, Roberts RO, Hass SL, Duhig AM, Smith CY, Emerson JA, Pankratz VS, Petersen RC. Direct medical costs and source of cost differences across the spectrum of cognitive decline: a population-based study. Alzheimers Dement. 2015;11(8):917–32. doi: 10.1016/j.jalz.2015.01.007. CrossRefPubMedPubMedCentral
Feng F, Han X, Chen J, et al. The application of activity of daily living scale in dementia screening. J Clin Psychiatry. 2004;04:193–4.
Erkinjuntti T, Bowler JV, DeCarli CS, Fazekas F, Inzitari D, O’Brien JT, Pantoni L, Rockwood K, Scheltens P, Wahlund LO, et al. Imaging of static brain lesions in vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord. 1999;13 Suppl 3:S81–90. PubMed
Wang G, Cheng Q, Zhang S, Bai L, Zeng J, Cui PJ, Zhang T, Sun ZK, Ren RJ, Deng YL, et al. Economic impact of dementia in developing countries: an evaluation of Alzheimer-type dementia in Shanghai. China Alzheimers Dis. 2008;15(1):109–15.
Alzheimer’s Disease International. World Alzheimer Report 2010: The global economic impact of dementia. Available at http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf. Accessed 21 Apr 2015.
Chan KY, Wang W, Wu JJ, Liu L, Theodoratou E, Car J, Middleton L, Russ TC, Deary IJ, Campbell H, et al. Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: a systematic review and analysis. Lancet. 2013;381(9882):2016–23. doi: 10.1016/S0140-6736(13)60221-4. CrossRefPubMed
Luo HQ, Qian JH, Wu K, Cao PY, Ren XH. Regional Differences and Determinants of Self-rated Health in Elderly. Sichuan Da Xue Xue Bao Yi Xue Ban. 2016;47(2):248–52.
Shen Y, Yeatts DE, Cai T, Yang PQ, Cready CM. Social capital and self-rated health among middle-aged and older adults in China: a multilevel analysis. Res Aging. 2014;36(4):497–521. doi: 10.1177/0164027513505624.
Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016;12(4):446-453.
- Monetary costs of Alzheimer’s disease in China: protocol for a cluster-randomised observational study
- BioMed Central